Sold out

Magnetic resonance imaging of the cerebral blood volume - Characterization of experimental brain tumor neovascularization

English · Paperback / Softback

Description

Read more

Cerebral blood volume fraction (CBVf) mapping by magnetic resonance imaging (MRI) can provide information about tumor angiogenesis. The Rapid Steady State T1 (RSST1) MRI method, based on a two-compartment model, intra- and extravascular, and on the longitudinal relaxivity of intravascular contrast agents (CAs), is developed and validated on healthy rats at 2.35 T (CBVf: 2 to 3%) using Gd-DOTA, approved for clinical use, and the experimental CA P760. Gd-ACX and SINEREM are evaluated for their blood pool properties in two rat glioma models C6 and RG2. The CBVf measures in tumor tissue are confirmed by histologic vascular morphometric analysis and were compared with those obtained by a DeltaR2 -based steady state method using the same SINEREM injection. In case of CA extravasation, such as occurs in tumor tissue with Gd-DOTA, the CBVf along with the transfer coefficient (related to the endothelial permeability) were obtained by pharmacokinetic two-compartment analysis of dynamic RSST1 acquisitions. In conclusion, the RSST1 method in conjunction with appropriate CAs can be used for longitudinal angiogenesis studies to quantify the CBVf and the vascular permeability.

Product details

Authors Hana Lahrech, Teodora-Adrian Perles-Barbacaru, Teodora-Adriana Perles-Barbacaru
Publisher LAP Lambert Academic Publishing
 
Languages English
Product format Paperback / Softback
Released 28.06.2012
 
EAN 9783659146114
ISBN 978-3-659-14611-4
No. of pages 452
Subject Natural sciences, medicine, IT, technology > Medicine > Medical professions

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.